Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Concert Pharmaceutic (NQ: CNCE )

6.960 -0.140 (-1.97%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 12, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 416,725
Open 7.130
Bid (Size) 6.750 (60)
Ask (Size) 7.000 (37)
Prev. Close 7.100
Today's Range 6.850 - 7.230
52wk Range 2.570 - 7.370
Shares Outstanding 32,173,778
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Recap: Concert Pharma Q2 Earnings
  Concert Pharma (NASDAQ:CNCE) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Concert Pharmaceuticals Reports Second Quarter 2022 Financial Results
From Concert Pharmaceuticals, Inc.
Via Business Wire

Performance

YTD
+105.92%
+105.92%
1 Month
+40.32%
+40.32%
3 Month
+76.20%
+76.20%
6 Month
+120.25%
+120.25%
1 Year
+104.71%
+104.71%

More News

Read More
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Concert Pharma Aces Second Trial For Patchy Hair Loss Hopeful
Via Benzinga
Concert Pharmaceuticals Reports Positive Topline Results for Second CTP‑543 Phase 3 Clinical Trial in Alopecia Areata
From Concert Pharmaceuticals, Inc.
Via Business Wire
Concert Pharmaceuticals to Report Second Quarter 2022 Results on August 4, 2022
From Concert Pharmaceuticals, Inc.
Via Business Wire
Lilly-Incyte Snag FDA Nod For Patchy Hair Loss Treatment — Smaller Rival's Stock Shoots Up In Sympathy
Via Benzinga
Concert Pharmaceuticals to Participate in Fireside Chat at The JMP Securities Life Sciences Conference
From Concert Pharmaceuticals, Inc.
Via Business Wire
Phase 2 Dose‑Ranging Clinical Trial Results of CTP‑543 in Patients with Alopecia Areata published in the Journal of the American Academy of Dermatology
From Concert Pharmaceuticals, Inc.
Via Business Wire
Concert Pharmaceuticals Raises Gross Proceeds of $66.4 Million Through Public Offering and Exercise of Warrants
From Concert Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
74 Biggest Movers From Yesterday
Via Benzinga
Concert Pharmaceuticals Announces Pricing of Public Offering
From Concert Pharmaceuticals, Inc.
Via Business Wire
53 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Drops 100 Points; Concert Pharmaceuticals Shares Plummet
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
62 Biggest Movers From Yesterday
Via Benzinga
Mid-Day Market Update: Dow Dips 200 Points; Tonix Pharmaceuticals Shares Spike Higher
Via Benzinga
44 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
18 Stocks Moving in Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Concert Pharmaceuticals Announces Proposed Public Offering of Common Stock
From Concert Pharmaceuticals, Inc.
Via Business Wire
70 Biggest Movers From Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.